Omega Therapeutics, Inc.
OMGAQ
$0.055
$0.0122.22%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.44M | -16.31M | -20.13M | -20.21M | -22.25M |
| Total Depreciation and Amortization | 3.10M | 613.00K | 1.82M | 1.78M | 1.86M |
| Total Amortization of Deferred Charges | 11.00K | 12.00K | 12.00K | 20.00K | 13.00K |
| Total Other Non-Cash Items | 1.73M | 1.21M | 3.43M | 2.13M | 2.29M |
| Change in Net Operating Assets | -2.41M | 1.80M | 3.07M | -806.00K | -4.95M |
| Cash from Operations | -14.02M | -12.67M | -11.81M | -17.09M | -23.04M |
| Capital Expenditure | -16.00K | -396.00K | -535.00K | -1.11M | -724.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 650.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 5.00M | 2.60M | 0.00 |
| Cash from Investing | -16.00K | -396.00K | 4.47M | 2.14M | -724.00K |
| Total Debt Issued | -- | -- | -- | 2.62M | -- |
| Total Debt Repaid | -1.45M | -1.11M | -1.09M | -1.00M | -- |
| Issuance of Common Stock | 2.00K | 0.00 | 22.00K | 2.00K | 7.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -15.00K |
| Cash from Financing | -1.44M | -1.11M | -1.07M | 1.63M | -8.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.48M | -14.18M | -8.41M | -13.33M | -23.77M |